|
Video: What is a Stock Split?
|
|
NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope. According to our NeoGenomics stock split history records, NeoGenomics has had 0 splits. | |
|
NeoGenomics (NEO) has 0 splits in our NeoGenomics stock split history database.
Looking at the NeoGenomics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NeoGenomics shares, starting with a $10,000 purchase of NEO, presented on a split-history-adjusted basis factoring in the complete NeoGenomics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$3.38 |
|
End price/share: |
$14.03 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
315.09% |
|
Average Annual Total Return: |
15.30% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$41,507.22 |
|
Years: |
10.00 |
|
|
|
|
|